To investigate the efficacy and safety of AK106-001616 in patients with rheumatoid arthritis.
Inclusion Criteria:
Exclusion Criteria:
Hlučín, Czechia
Hostivice, Czechia
Prague, Czechia
Uherské Hradiště, Czechia
Zlín, Czechia
Berlin, Germany
Frankfurt, Germany
Hamburg, Germany
Balatonfüred, Hungary
Budapest, Hungary
Debrecen, Hungary
Bialystok, Poland
Elblag, Poland
Lublin, Poland
Poznan, Poland
Warsaw, Poland
Bratislava, Slovakia
Martin, Slovakia
Donetsk, Ukraine
Kharkiv, Ukraine
Kyiv, Ukraine
Ternopil, Ukraine
Vinnytsa, Ukraine
Zaporizhzhya, Ukraine
Cambridge, United Kingdom
Sheffield, United Kingdom